ENOB RSI Chart
Last 7 days
20.3%
Last 30 days
14.7%
Last 90 days
-43.0%
Trailing 12 Months
-71.7%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2016 | 43.7K | 43.1K | 0 | 0 |
2015 | 0 | 0 | 0 | 43.7K |
2013 | 55.3K | 47.8K | 40.3K | 32.8K |
2012 | 0 | 0 | 0 | 62.8K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Jun 26, 2023 | sindlev rene | acquired | 1,000,000 | 0.53 | 1,886,790 | - |
Mar 17, 2023 | sindlev rene | acquired | 1,000,000 | 1.14 | 877,193 | - |
Oct 13, 2022 | weird science llc | acquired | - | - | 1,216,470 | - |
Oct 13, 2022 | william anderson wittekind | acquired | - | - | 1,216,470 | - |
Jun 08, 2022 | sindlev rene | sold | - | - | -125,000 | - |
Jun 08, 2022 | sindlev rene | sold | - | - | -128,493 | - |
May 18, 2022 | sindlev rene | bought | 1,027,940 | 8.00 | 128,493 | - |
May 18, 2022 | gumrukcu serhat | sold | -2,027,940 | 8.00 | -253,493 | - |
May 18, 2022 | sindlev rene | bought | 1,000,000 | 8.00 | 125,000 | - |
Apr 15, 2022 | weird science llc | sold | - | - | -4,961,360 | - |
Which funds bought or sold ENOB recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 11, 2024 | VANGUARD GROUP INC | added | 43.78 | 23,817 | 1,236,640 | -% |
Mar 01, 2024 | GOLDMAN SACHS GROUP INC | new | - | 81,602 | 81,602 | -% |
Feb 26, 2024 | Virtu Financial LLC | new | - | 59,000 | 59,000 | -% |
Feb 15, 2024 | JANE STREET GROUP, LLC | new | - | 179,841 | 179,841 | -% |
Feb 14, 2024 | BNP PARIBAS FINANCIAL MARKETS | reduced | -64.74 | -11,382 | 3,794 | -% |
Feb 14, 2024 | MSA Advisors, LLC | new | - | 79,250 | 79,250 | 0.03% |
Feb 14, 2024 | LAZARD ASSET MANAGEMENT LLC | new | - | 12,000 | 12,000 | -% |
Feb 14, 2024 | Balyasny Asset Management L.P. | new | - | 81,637 | 81,637 | -% |
Feb 14, 2024 | MILLENNIUM MANAGEMENT LLC | reduced | -34.12 | -456,627 | 400,415 | -% |
Feb 14, 2024 | Laurion Capital Management LP | new | - | 194,904 | 194,904 | -% |
Unveiling Enochian Biosciences, Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Enochian Biosciences, Inc. News
Income Statement (Quarterly) | |||||||||
Description | (%) Q/Q | 2016Q2 | 2016Q1 | 2015Q4 | 2013Q4 | 2013Q3 | 2013Q2 | 2013Q1 | 2012Q4 |
Revenue | - | 244 | - | 42,525 | 285 | 925 | - | 31,558 | - |
Gross Profit | - | 213 | - | 37,281 | -40,528 | -15,273 | -36,928 | 16,198 | - |
Income Taxes | 1276.7% | 397,824 | -33,808 | -340,103 | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | 0.8% | 58.00 | 58.00 | 58.00 | 79.00 | 80.00 | 83.00 | 85.00 | 180 | 183 | 184 | 190 | 174 | 173 | 175 | 178 | 181 | 178 | 181 | 180 | 178 | 181 |
Current Assets | 26.1% | 2.00 | 2.00 | 3.00 | 4.00 | 5.00 | 8.00 | 10.00 | 12.00 | 15.00 | 15.00 | 21.00 | 5.00 | 4.00 | 6.00 | 9.00 | 11.00 | 9.00 | 11.00 | 12.00 | 11.00 | 13.00 |
Cash Equivalents | -53.4% | 0.00 | 1.00 | 2.00 | 3.00 | 4.00 | 8.00 | 9.00 | 11.00 | 14.00 | 15.00 | 21.00 | 5.00 | 3.00 | 6.00 | 9.00 | 11.00 | 9.00 | 11.00 | 12.00 | 10.00 | 13.00 |
Net PPE | 3.0% | 0.00 | 0.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Goodwill | 0% | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 |
Liabilities | 33.3% | 14.00 | 11.00 | 12.00 | 13.00 | 13.00 | 13.00 | 12.00 | 19.00 | 18.00 | - | 15.00 | 11.00 | 11.00 | 11.00 | 12.00 | 10.00 | 7.00 | 8.00 | 7.00 | 25.00 | 25.00 |
Current Liabilities | 36.3% | 14.00 | 10.00 | 11.00 | 12.00 | 11.00 | 7.00 | 6.00 | 8.00 | 6.00 | 1.00 | 2.00 | 1.00 | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 2.00 | 2.00 |
Shareholder's Equity | -6.7% | 44.00 | 47.00 | 47.00 | 66.00 | 67.00 | 70.00 | 73.00 | 161 | 166 | 167 | 175 | 162 | 162 | 164 | 166 | 170 | 171 | 172 | 173 | 153 | 155 |
Retained Earnings | -1.8% | -257 | -253 | -244 | -220 | -216 | -212 | -204 | -114 | -107 | -101 | -90.91 | -73.55 | -69.52 | -66.58 | -64.19 | -60.09 | -58.58 | -56.86 | -52.77 | -53.94 | -51.21 |
Additional Paid-In Capital | 0.4% | 301 | 300 | 291 | 287 | 283 | 282 | 277 | 275 | 274 | 268 | 266 | 236 | 231 | 231 | 230 | 230 | 230 | 229 | 226 | 206 | 206 |
Shares Outstanding | 2.3% | 67.00 | 66.00 | 64.00 | 58.00 | 55.00 | 55.00 | 53.00 | 53.00 | 53.00 | 52.00 | 52.00 | 48.00 | 47.00 | 47.00 | - | - | - | - | - | - | - |
Float | - | - | - | - | - | 45.00 | - | - | - | 243 | - | - | - | 83.00 | - | - | - | 69.00 | - | - | - | 72.00 |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | -13.3% | -3,146 | -2,777 | -2,261 | -3,307 | -3,551 | -2,653 | -3,050 | -2,784 | -4,620 | -5,276 | -13,028 | -2,330 | -2,496 | -2,755 | -2,245 | -3,838 | -2,575 | -1,800 | -2,218 | -2,737 | -1,754 |
Share Based Compensation | 1.6% | 999 | 984 | - | - | 820 | 1,026 | -110 | 578 | 2,043 | 2,728 | 186 | 352 | 359 | 326 | -11.25 | -28.09 | 690 | 234 | 162 | 97.00 | 1,780 |
Cashflow From Investing | 94.6% | -57.33 | -1,057 | -6.14 | - | - | - | - | - | - | -5.16 | -38.17 | - | -10.72 | - | -10.45 | -41.69 | -63.70 | -68.62 | 17.00 | -92.63 | -332 |
Cashflow From Financing | 11.1% | 2,847 | 2,563 | 1,248 | 2,109 | -300 | 1,458 | 1,070 | 230 | 2,951 | - | 29,203 | 3,439 | -40.41 | - | - | 6,200 | - | 1,000 | 4,320 | - | - |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2023 | Dec. 31, 2022 | |
Operating Expenses | ||||
General and administrative | $ 3,616,392 | $ 4,013,063 | $ 11,906,602 | $ 8,569,903 |
Research and development | 620,521 | 325,959 | 1,187,165 | 2,931,334 |
Depreciation and amortization | 33,162 | 28,844 | 60,422 | 57,245 |
Total Operating Expenses | 4,270,075 | 4,367,866 | 13,154,189 | 11,558,482 |
LOSS FROM OPERATIONS | (4,270,075) | (4,367,866) | (13,154,189) | (11,558,482) |
Other Income (Expenses) | ||||
Loss on extinguishment of debt | (120,018) | |||
Loss on extinguishment of contingent consideration | (419,182) | |||
Interest expense | (274,984) | (92,892) | (454,255) | (188,477) |
Interest and other income | 15,938 | 3,010 | 24,313 | 8,633 |
Total Other Income (Expense) | (259,046) | (89,882) | (549,960) | (599,026) |
NET LOSS | $ (4,529,121) | $ (4,457,748) | $ (13,704,149) | $ (12,157,508) |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) | Dec. 31, 2023 | Jun. 30, 2023 |
---|---|---|
CURRENT ASSETS: | ||
Cash | $ 243,980 | $ 1,874,480 |
Notes receivable | 1,073,625 | |
Prepaids and other assets | 1,085,545 | 690,925 |
Total Current Assets | 2,403,150 | 2,565,405 |
Property and equipment, net | 496,896 | 508,989 |
OTHER ASSETS: | ||
Definite life intangible assets, net | 32,641 | 39,676 |
Indefinite life intangible assets | 42,611,000 | 42,611,000 |
Goodwill | 11,640,000 | 11,640,000 |
Deposits and other assets | 21,742 | 21,741 |
Operating lease right-of-use assets | 812,691 | 913,985 |
Total Other Assets | 55,118,074 | 55,226,402 |
TOTAL ASSETS | 58,018,120 | 58,300,796 |
CURRENT LIABILITIES: | ||
Accounts payable – trade | 5,577,917 | 5,296,823 |
Accrued expenses | 783,601 | 723,173 |
Other current liabilities | 669,384 | 184,733 |
Current portion of operating lease liabilities | 218,085 | 193,422 |
Notes payable, net | 3,940,000 | 4,624,947 |
Convertible notes payable | 2,569,379 | |
Total Current Liabilities | 13,758,366 | 11,023,098 |
NON-CURRENT LIABILITIES: | ||
Operating lease liabilities, net of current portion | 664,218 | 775,587 |
Total Non-Current Liabilities | 664,218 | 775,587 |
Total Liabilities | 14,422,584 | 11,798,685 |
Commitments and Contingencies | ||
STOCKHOLDERS’ EQUITY: | ||
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; Series A Convertible Preferred;1,000,000 shares designated; 561,010 shares issued and outstanding at December 31, 2023 and zero 0 shares issued and outstanding at June 30, 2023 | 56 | |
Common Stock, par value $0.0001, 100,000,000 shares authorized, 67,224,089 shares issued and outstanding at December 31, 2023, and 63,698,144 shares issued and outstanding at June 30, 2023 | 6,724 | 6,371 |
Additional paid-in capital | 301,349,389 | 290,554,875 |
Accumulated deficit | (257,733,402) | (244,029,253) |
Accumulated other comprehensive loss | (27,231) | (29,882) |
Total Stockholders’ Equity | 43,595,536 | 46,502,111 |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ 58,018,120 | $ 58,300,796 |